Moreover, we showed that CDC42 inhibitor (ZCL278) could significantly weaken CEMIP-induced EMT (Fig. 6B), and knock-down of CEMIP inhibited EMT of CRC cells, which was further suppressed by CDC42 inhibitor (Supplementary Fig. S10, B). Here, CDC42 is linked to colorectal carcinoma.